Skin Ulcer
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
MLM BiologicsFL - Gainesville
1 programBio-ConneKt Wound Dressing for Treatment of Chronic Leg Wounds: A Pilot StudyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Heidelberg Pharmathermotherapy
MLM BiologicsBio-ConneKt Wound Dressing for Treatment of Chronic Leg Wounds: A Pilot Study
Clinical Trials (2)
Total enrollment: 5,020 patients across 2 trials
Treat Early and Broad: Thermotherapy of Buruli Ulcer Integrated Into WHO-recommended Wound Management in West Africa
Start: May 2019Est. completion: Sep 20245,000 patients
N/AUnknown
NCT02309684MLM BiologicsBio-ConneKt Wound Dressing for Treatment of Chronic Leg Wounds: A Pilot Study
Bio-ConneKt Wound Dressing for Treatment of Chronic Leg Wounds: A Pilot Study
Start: Jan 2015Est. completion: Jan 201620 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.